Acumen Pharmaceuticals annual total assets
2020
2021
2022
2023
2024
2025
Acumen Pharmaceuticals Total Assets Growth & History (ABOS)
Acumen Pharmaceuticals's total assets was $122.8M for fiscal 2025.
View full Acumen Pharmaceuticals company overviewAcumen Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $122.8M | −$116.2M | −48.60% |
| 2024 | 2024-12-31 | $239.0M | −$71.1M | −22.94% |
| 2023 | 2023-12-31 | $310.1M | $113.5M | +57.75% |
| 2022 | 2022-12-31 | $196.6M | −$33.7M | −14.65% |
| 2021 | 2021-12-31 | $230.3M | $185.9M | +418.42% |
| 2020 | 2020-12-31 | $44.4M | — | — |
Acumen Pharmaceuticals quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $116.0M | −$55.9M | −32.51% |
| Q1 2026 | 2026-03-31 | $133.6M | −$70.8M | −34.65% |
| Q4 2025 | 2025-12-31 | $122.8M | −$116.2M | −48.60% |
| Q3 2025 | 2025-09-30 | $142.2M | −$124.8M | −46.73% |
| Q2 2025 | 2025-06-30 | $171.9M | −$117.0M | −40.50% |
| Q1 2025 | 2025-03-31 | $204.5M | −$96.5M | −32.06% |
| Q4 2024 | 2024-12-31 | $239.0M | −$71.1M | −22.94% |
| Q3 2024 | 2024-09-30 | $267.0M | −$19.4M | −6.77% |
| Q2 2024 | 2024-06-30 | $288.9M | $111.5M | +62.86% |
| Q1 2024 | 2024-03-31 | $301.0M | $113.1M | +60.20% |
| Q4 2023 | 2023-12-31 | $310.1M | $113.5M | +57.75% |
| Q3 2023 | 2023-09-30 | $286.4M | $83.1M | +40.89% |
| Q2 2023 | 2023-06-30 | $177.4M | −$34.3M | −16.19% |
| Q1 2023 | 2023-03-31 | $187.9M | −$32.2M | −14.64% |
| Q4 2022 | 2022-12-31 | $196.6M | −$33.7M | −14.65% |
| Q3 2022 | 2022-09-30 | $203.3M | −$31.6M | −13.45% |
| Q2 2022 | 2022-06-30 | $211.7M | $138.7M | +190.20% |
| Q1 2022 | 2022-03-31 | $220.1M | — | — |
| Q4 2021 | 2021-12-31 | $230.3M | $185.9M | +418.42% |
| Q3 2021 | 2021-09-30 | $234.8M | — | — |
| Q2 2021 | 2021-06-30 | $72.9M | — | — |
| Q4 2020 | 2020-12-31 | $44.4M | — | — |
Acumen Pharmaceuticals total assets trends
Over the last five fiscal years, Acumen Pharmaceuticals's total assets increased from $44.4M to $122.8M, a change of $78.4M. The latest reported quarter, Q2 2026, shows $116.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acumen Pharmaceuticals source filings ↗